Abstract

Speckle-type POZ domain protein (SPOP), an adaptor in the E3 ubiquitin ligase complex, recognizes substrates and promotes protein degradation via the ubiquitin-proteasome system. It appears to help regulate progression of several cancers, and we show here that it acts as a tumor suppressor in pancreatic cancer. Our analysis of patient tissues showed decreased SPOP expression, which was associated with poor prognosis. SPOP knockdown in SW1990 (in vitro/vivo) and PANC-1 (in vitro) cells led to significantly greater proliferation, migration, and invasion. Co-immunoprecipitation experiments in SW1990 cells showed that SPOP interacted with the stem-cell marker NANOG, and this interaction has recently been shown to play a critical role in regulating progression of prostate cancer. We showed that, in one patient with pancreatic cancer, the expression of a truncated form of SPOP (p.Q360*) lacking the nuclear localization signal led to nuclear accumulation of NANOG, which promoted growth and metastasis of pancreatic cancer cells. Our results suggest that SPOP suppresses progression of pancreatic cancer by promoting the ubiquitination and subsequent degradation of NANOG. These results identify the SPOP-NANOG interaction as a potential therapeutic target against pancreatic cancer.

Highlights

  • Pancreatic cancer is characterized by poor prognosis and high mortality

  • Low expression of Speckle-type POZ domain protein (SPOP) correlates with poor prognosis in pancreatic cancer A total of 21 pancreatic ductal adenocarcinoma tissues and adjacent non-tumor tissues were assayed for SPOP levels using western blotting (WB) and immunohistochemistry

  • It was downregulated in most pancreatic cancer patients in our study, and low SPOP expression correlated with poor prognosis

Read more

Summary

Introduction

Pancreatic cancer is characterized by poor prognosis and high mortality. In 2018, an estimated 458,000 new cases of pancreatic cancer and 432,000 deaths related to the disease were recorded worldwide[1]. The length and type of ubiquitination affect the fate of the protein[4,5]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.